ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.6749A>T (p.Glu2250Val)

dbSNP: rs2043018196
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV003444814 SCV001468416 likely pathogenic Marfan syndrome 2021-12-09 criteria provided, single submitter clinical testing This variant has not been reported in the literature and is absent from gnomAD. This variant is located in a calcium-binding epidermal growth factor-like (cbEGF) domain and may impair protein folding or stabilization (Jensen 2005 PMID:15649891). Additionally, the FBN1 gene has a gnomAD missense constraint z-score of 5.06, suggesting that benign missense variation in FBN1 is uncommon (Lek 2016 PMID: 27535533). Of note, a likely pathogenic variant at the same amino acid position (p.Glu2250Gly) has been reported in the literature in two individuals with ectopia lentis and other features consistent with Marfan syndrome (Comeglio 2007 PMID: 17657824; Söylen 2009 PMID: 19159394). Evolutionary conservation and computational predictive tools further support the potential impact to protein structure or function. In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.